References
- Farup P G, Larsen S, Ulshagen K, Osnes M. Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment. Scand J Gastroenterol 1991; 26: 1209–16
- Gotthard R, Bodemar G, Brodin U, Jönsson KÅ. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988; 23: 7–18
- Johannessen T, Fjösne U, Kleveland P M, Halvorsen T, Kristensen P, Loge I, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988; 23: 327–36
- Nyrén O, Adami H O, Bates S, Bergström R, Gustavsson S, Lööf L, et al. Absence of therapeutic benefit from antacids or cime-tidine in non-ulcer dyspepsia. N Engl J Med 1986; 314: 339–43
- Hansen J M, Bytzer P, Schaffalitzky de Muckadell OB. Placebo-controlled trial of cisapride and nizatidine in unselected patients with non-ulcer dyspepsia. Gastroenterology 1994; 106: 994, Suppl A89
- Ryder S D, O'Reilly S, Miller R J, Ross J, Jacyna M R, Levi A J. Long term acid suppressing treatment in general practice. Br Med J 1994; 308: 827–30
- Thors H, Sigurdsson H, Oddsson E, Thjodleifsson B. Survey of prescriptions for peptic ulcer drugs (ACT class AOB2) in Iceland. Scand J Gastroenterol 1994; 29: 988–94
- Larsen S, Farup P, Flaten O, Osnes M. The multi-crossover model for classifying patients as responders to a given treatment. Scand J Gastroenterol 1991; 26: 763–70
- Saunders JHB, Oliver R J, Higson DL. Dyspepsia: incidence of non-ulcer disease in a controlled trial of ranitidine in general practice. Br Med J 1986; 292: 665–8
- Kleveland P M, Larsen S, Sandvik L, Kristensen P, Johannessen T, Hafstad P E, et al. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. Scand J Gastroenterol 1985; 20: 19–24
- Johannessen T, Kristensen P, Petersen H, Fosstvedt D, Loge I, Kleveland P M, et al. The symptomatic effect of 1 -day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled single-subject trials. Scand J Gastroenterol 1991; 26: 974–80
- Kagevi I, Löfstedt S, Persson LG. Endoscopic findings and diagnosis in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol 1989; 24: 145–50
- Pfeiffer A, Aronbayev J, Schmidt T, Wendl B, Pehl C, Kaess H. Gastric emptying, esophageal 24-hour pH and gastric potential difference measurements in non-ulcer dyspepsia. Gastroenterol Clin Biol 1992; 16: 395–400
- Klauser A G, Voderholzer W A, Knesewitsch P A, Schindlbeck N E, Miiller-Lissner SA. What is behind dyspepsia?. Dig Dis Sci 1993; 38: 147–54
- Karnad D R, Abraham P, Rathod N M, Nazareth H M. Test for H2-antagonist response in non-ulcer dyspepsia. Lancet 1990; 335: 657–8
- George A A, Tsuchiyose M, Dooley CP. Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia. Gastroenterology 1991; 101: 3–6
- Misra S P, Broor S L. Is gastric acid responsible for the pain in patients with essential dyspepsia?. J Clin Gastroenterol 1990; 12: 624–7
- DeBoer W A, Tytgat GNJ. Review article: drug therapy for reflux oesophagitis. Aliment Pharmacol Ther 1994; 8: 147–57
- Johannessen T, Petersen H, Kristensen P, Fosstvedt D, Kleveland P M, Dybdahl J, et al. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. Scand J Gastroenterol 1992; 27: 189–95
- Klauser A G, Schindlbeck N E, Miiller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990; 335: 205–8
- Shi G, des Varannes S B, Scarpignato C, Le Rhun M, Galmich J-P. Reflux related symptoms in patients with normal oesophageal exposure to acid. Gut 1995; 37: 457–64
- Farup P G, Hovde O, Breder O. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine. Scand J Gastroenterol 1995; 30: 829–32
- Holtmann G, Goebell H, Holtmann M, Talley N J. Dyspepsia in healthy blood donors. Pattern of symptoms and association with Helicobacter pylori. Dig Dis Sci 1994; 39: 1090–8
- Schlemper R J, van der Werf SDJ, Vandenbroucke J P, Biemond I, Lamers CBHW. Nonulcer dyspepsia in a dutch working population and Helicobacter pylori. Ulcer history as an explanation of an apparent association. Arch Intern Med 1995; 155: 82–7
- Agréus L, Engstrand L, Svärdsudd K, Nyrén O, Tibblin G. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. A population-based epidemiologic study. Scand J Gastroenterol 1995; 30: 752–7
- Talley N J. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994; 106: 1174–83
- McCarthy C, Patchett S, Collins R M, Beattie S, Keane C, O'Moráin C. Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia. Dig Dis Sci 1995; 40: 114–9
- Jebbink HJA, Smout AJPM, van Berge-Henegouwen GP. Pathophysiology and treatment of functional dyspepsia. Scand J Gastroenterol 1993; 28: 8–14, Suppl 200